Cepheid Reagent Test Cartridges and Consumables - Phoenix Area Wide

This is a notification of an intent to award a contract to Cepheid, under NAICS code 325413 In-Vitro Diagnostic Substance Manufacturing by Indian Health Services under the authority of FAR 6.302-1, Only One Responsible Source. This requirement is to secure molecular diagnostic reagent test kits and consumables compatible with the Cepheid GeneXpert Xpress platform. Test kits include COVID-19 or Combination test kits used to test for COVID-19, Influenza A+B, and Respiratory Syncytial Virus and sexually transmitted infections, and other clinically significant bacterial infection detections such as Methicillin-Resistant S. aureus (MRSA) and C. difficile.

If you can provide the supplies requested, all responsible sources may submit a capability statement, which shall be considered by the Agency and may be e-mailed to Ashley.Velasquez@ihs.gov referencing notice number PHX-SS-23-002 by 8 AM PDT, October 27, 2022. A determination by the Government not to compete this proposed contract acquisition based upon responses to the notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. This notice does not obligate the Government to award a contract or otherwise pay for information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed. Information provided will be used to assess tradeoffs and alternatives available for the potential requirement and may lead to the development of a solicitation. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.

Any solicitation resulting from the analysis of information obtained will be announced to the public in Federal Business Opportunities in accordance with the FAR Part 5. However, responses to this notice will not be considered adequate responses to a solicitation. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

See attached table of supplies.